Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 2/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL724893 | 0.91 | ALDH1A1 (0.50) | HTR6HPGDKMT2AMEN1LMNA | |
| SCHEMBL725823 | 0.85 | KMT2A (0.46) | HTR6HPGDKMT2AMEN1LMNA | |
| (Phenylsulfonyl)Benzene SCHEMBL29100684 | 0.84 | HTR6 (0.54) | HTR6HPGDKMT2AMEN1LMNA | |
| SCHEMBL165237 | 0.83 | HTR6 (0.64) | HTR6HPGDKMT2AMEN1LMNA | |
| SCHEMBL12123514 | 0.82 | MAPT (0.53) | HPGDKMT2ALMNAMAPTALDH1A1 | |
| SCHEMBL14387536 | 0.82 | ALDH1A1 (0.42) | HTR6HPGDKMT2AMEN1LMNA | |
| SCHEMBL7311605 | 0.82 | GAA (0.64) | HPGDKMT2AMEN1LMNAMAPT | |
| SCHEMBL11594739 | 0.81 | CES2 (0.65) | HTR6HPGDKMT2AMEN1LMNA | |
| SCHEMBL9769557 | 0.80 | POLB (0.55) | HPGDKMT2AMEN1LMNAL3MBTL1 | |
| (Phenylsulfonyl)Benzene SCHEMBL7774155 | 0.79 | HTR6 (0.82) | HTR6HPGDKMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118703088-B | Ageing-resistant acrylic resin waterproof paint | 内蒙古安特威盾防水科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-118703088-A | Ageing-resistant acrylic resin waterproof paint | 内蒙古安特威盾防水科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118703088-B | Ageing-resistant acrylic resin waterproof paint | 内蒙古安特威盾防水科技有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-118703088-A | Ageing-resistant acrylic resin waterproof paint | 内蒙古安特威盾防水科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| US-11773068-B2 | KDM1A inhibitors for the treatment of disease | IMAGO BIOSCIENCES, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-11230534-B2 | KDM1A inhibitors for the treatment of disease | IMAGO BIOSCIENCES, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| US-20200283397-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | IMAGO BIOSCIENCES, INC. | 2020-09-10 | — | — | US | disclosed |
| US-20200283403-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2020-09-10 | — | — | US | disclosed |
| US-10647695-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2020-05-12 | — | — | US | disclosed |
| US-20190270721-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2019-09-05 | — | — | US | disclosed |
| US-5428161-A | Having at least one electron-withdrawing substituent on at least one of the groups attached to the amine groups at the 3- and 7-positions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-06-27 | — | — | US | disclosed |
| EP-0244399-B1 | NOVEL PHENAZINE DYES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-05-30 | — | — | EP | disclosed |
| US-4889932-A | THERMOGRAPHY; COATINGS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-12-26 | — | — | US | disclosed |
| EP-0339869-A2 | Novel phenazine dyes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-11-02 | — | — | EP | disclosed |
| EP-0181085-B1 | STABILIZED LEUCO PHENAZINE DYES AND THEIR USE IN AN IMAGING SYSTEM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-08-09 | — | — | EP | disclosed |
| EP-0244399-A1 | NOVEL PHENAZINE DYES. | MINNESOTA MINING & MFG (US) | 1987-11-11 | — | — | EP | disclosed |
| WO-1987002048-A1 | NOVEL PHENAZINE DYES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-04-09 | — | — | WO | disclosed |
| US-4647525-A | Stabilized leuco phenazine dyes and their use in an imaging system | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-03-03 | — | — | US | disclosed |
| EP-0181085-A1 | Stabilized leuco phenazine dyes and their use in an imaging system | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1986-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647695-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNT, NQO1 | HTR6 1044/4885HPGD 199/4885KMT2A 659/4885 |
| US-20200283403-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, HAMP, NQO1 | HTR6 1196/4885HPGD 335/4885KMT2A 1299/4885 |
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNT, NQO1 | HTR6 1044/4885HPGD 199/4885KMT2A 659/4885 |
| US-20200283397-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | KDM1B, KDM1A, KDM2A | HTR6 3374/4885HPGD 1669/4885KMT2A 14/4885 |
| US-11230534-B2 | KDM1A inhibitors for the treatment of disease | KDM1B, KDM1A, KDM2A | HTR6 3374/4885HPGD 1669/4885KMT2A 14/4885 |
| US-11773068-B2 | KDM1A inhibitors for the treatment of disease | KDM1B, KDM1A, KDM2A | HTR6 3374/4885HPGD 1669/4885KMT2A 14/4885 |
| US-20190270721-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, HAMP, NQO1 | HTR6 1196/4885HPGD 335/4885KMT2A 1299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.